Amedisys Signs Definitive Agreement to Acquire RoseRock Healthcare
February 19 2019 - 4:30PM
Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home
health, hospice and personal care company, has signed a definitive
agreement to acquire RoseRock Healthcare, a hospice care provider
in Tulsa, Oklahoma.
Under the terms of the agreement, expected to close on April 1,
2019, Amedisys will acquire substantially all the assets of
RoseRock Healthcare.
RoseRock provides specialized hospice care to approximately 200
patients daily in northeastern Oklahoma. Amedisys currently
operates six home health care centers in Oklahoma, including an
agency in Tulsa.
“I’d like to first welcome all of the dedicated caregivers from
RoseRock Healthcare – you are joining a nationwide company of
caregivers at Amedisys, and I know you’ll fit right in,” stated
President and Chief Executive Officer Paul Kusserow. “Secondly,
thank you for your commitment to excellent patient care. We are so
excited to have the privilege of continuing the RoseRock tradition
of honoring life with the best care possible to the Tulsa
community.”
On the close of the agreement, Amedisys will operate 138 hospice
care centers in 34 states. The Company recently closed on its
acquisition of Compassionate Care Hospice, a 53-location national
hospice care provider that added 11 states to Amedisys’ hospice
network.
“Whether we’re delivering care at a patient’s bedside,
supporting our clinical team or educating the community on the
hospice benefit, hospice isn’t just a job – it’s our calling,”
stated Regarner Thompson, Senior Vice President of Hospice, South
Region. “We know our patients and our team members will benefit by
coming together with a strongly aligned culture and commitment to
excellent patient care.”
Media Contact:Kendra
Kimmons
Vice President of Marketing &
Communications 225-299-3708
kendra.kimmons@amedisys.com |
Investor Contact:Nick
Muscato Vice President of Strategic
Finance 615-928-5452 nick.muscato@amedisys.com |
|
|
Forward-Looking Statements
When included in this press release, words like “believes,”
“belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,”
“estimates,” “may,” “might,” “would,” “should,” “will” and similar
expressions are intended to identify forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
These forward-looking statements include, but are not limited to,
statements regarding the expected timing of completion of the
proposed acquisition of RoseRock Healthcare and the expected
effects of the completion of the proposed acquisition. These
forward-looking statements involve a variety of risks and
uncertainties that could cause actual results to differ materially
from those described therein. These risks and uncertainties
include, but are not limited to the following: our ability to close
the acquisition of RoseRock Healthcare, our ability to realize the
anticipated benefits of the acquisition of RoseRock Healthcare,
changes in Medicare and other medical payment levels, our ability
to open care centers, acquire additional care centers and integrate
and operate these care centers effectively, changes in or our
failure to comply with existing federal and state laws or
regulations or the inability to comply with new government
regulations on a timely basis, competition in the healthcare
industry, changes in the case mix of patients and payment
methodologies, changes in estimates and judgments associated with
critical accounting policies, our ability to maintain or establish
new patient referral sources, our ability to attract and retain
qualified personnel, changes in payments and covered services by
federal and state governments, future cost containment initiatives
undertaken by third-party payors, our access to financing, our
ability to meet debt service requirements and comply with covenants
in debt agreements, business disruptions due to natural disasters
or acts of terrorism, our ability to integrate, manage and keep our
information systems secure, our ability to comply with requirements
stipulated in our corporate integrity agreement, our ability to
realize the anticipated benefits of the acquisition of
Compassionate Care Hospice, and changes in law or developments with
respect to any litigation relating to the Company, including
various other matters, many of which are beyond our control.
Because forward-looking statements are inherently subject to
risks and uncertainties, some of which cannot be predicted or
quantified, you should not rely on any forward-looking statement as
a prediction of future events. We expressly disclaim any obligation
or undertaking and we do not intend to release publicly any updates
or changes in our expectations concerning the forward-looking
statements or any changes in events, conditions or circumstances
upon which any forward-looking statement may be based, except as
required by law.
About Amedisys: Amedisys,
Inc. is a leading healthcare at home Company delivering
personalized home health, hospice and personal care. Amedisys is
focused on delivering the care that is best for our patients,
whether that is home-based personal care; recovery and
rehabilitation after an operation or injury; care focused on
empowering them to manage a chronic disease; or hospice care at the
end of life. More than 3,000 hospitals and 65,000 physicians
nationwide have chosen Amedisys as a partner in post-acute care.
Founded in 1982, headquartered in Baton Rouge, LA with an executive
office in Nashville, TN, Amedisys is a publicly held company. With
more than 21,000 employees in 472 care centers in 38 states and the
District of Columbia, Amedisys is dedicated to delivering the
highest quality of care to the doorsteps of more than 376,000
patients and clients in need every year. For more information about
the Company, please visit: www.amedisys.com.
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024